Acetylacetonato(1,5-cyclooctadiene)rhodium(I)

CAS: 12245-39-5

Ref. 3D-FA37606

Produktinformation

• Name: Acetylacetonato(1,5-cyclooctadiene)rhodium(I)
• Synonyme: (1,5-Cyclooctadiene)(2,4-pentadionato)rhodium(I), (1,5-Cyclooctadiene)(acetylacetonate)rhodium, (1,5-Cyclooctadiene)(acetylacetonato)rhodium(I), (1,5-Cyclooctadiene)rhodium acetylacetonate, (1-Methyl-3-Oxoniumylidene-Butylidene)Oxonium, (1Z,5Z)-cycloocta-1,5-diene, (Acetylacetonato)(1,5-cyclooctadiene)rhodium, (Acetylacetonato)(cyclooctadiene)rhodium, (Acetylacetonato)(η⁴-1,5-cyclooctadiene)rhodium, 1,5-Cyclooctadiene, rhodium complex, Acetylacetonate(1,5-cyclooctadiene)rhodium, Acetylacetonate(cyclooctadiene)rhodium, NSC 240030, Pentane-2,4-Dione, Rhodium, Rhodium (1,5-cyclooctadiene)-2,4-pentanedionate, Rhodium, (1,5-cyclooctadiene)(2,4-pentanedionato)-, Rhodium, (2,4-pentanedionato)(1,5-cyclooctadiene)-, Rhodium, [(1,2,5,6-η)-1,5-cyclooctadiene](2,4-pentanedionato-O,O′)-, Rhodium, [(1,2,5,6-η)-1,5-cyclooctadiene](2,4-pentanedionato-κO,κO′)-, Rhodium, [(1,2,5,6-η)-1,5-cyclooctadiene](2,4-pentanedionato-κO²,κO⁴)-, [(1,2,5,6-η)-1,5-Cyclooctadiene](2,4-pentanedionato-κO²,κO⁴)rhodium
• CAS: 12245-39-5

Beschreibung

Acetylacetonato(1,5-cyclooctadiene)rhodium(I) (ACR) is a palladium compound that has significant activity against the L1210 tumour in mice. It inhibits the growth of cancer cells by binding to amines and heterocycles in the DNA. ACR also binds to DNA and alters its structure, inhibiting transcription and replication. This agent has shown to be effective against tumours induced by various carcinogens in rats. The antitumour activity of ACR may be due to its ability to inhibit cell division, induce apoptosis, or alter cell metabolism. Acetylacetonato(1,5-cyclooctadiene)rhodium(I) can also affect the intestinal epithelium, causing an inflammatory response or histological damage.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 310.19 g/mol
• Formel: C₁₃H₁₉O₂Rh
• Reinheit: Min. 95%